Ardmore, PA, United States of America

Gretchen L Temeles


Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gretchen L. Temeles

Introduction

Gretchen L. Temeles is a notable inventor based in Ardmore, PA (US). He has made significant contributions to the field of molecular biology, particularly in understanding RNA interactions. With a total of 2 patents, his work has implications for both research and therapeutic applications.

Latest Patents

Gretchen's latest patents include a method for identifying compounds that affect RNA/RNA binding protein interactions. This invention discloses nucleic acid sequences that, when present in an RNA molecule, bind to RNA binding proteins. These sequences are found in untranslated regions of certain mRNA and can be utilized in assays to identify compounds that influence these interactions. The second patent focuses on a functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements. This invention features cDNA libraries that consist of cDNA sequences corresponding to different mRNA untranslated region sequences, separate from adjacent mRNA coding sequences.

Career Highlights

Gretchen L. Temeles has established himself as a key figure in the biotechnology sector. He is currently associated with Message Pharmaceuticals, Inc., where he continues to innovate and contribute to advancements in molecular biology.

Collaborations

Throughout his career, Gretchen has collaborated with notable colleagues, including Tony Giordano and Deborah L. Beach. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Gretchen L. Temeles exemplifies the spirit of innovation in the field of molecular biology. His patents and ongoing work contribute significantly to our understanding of RNA interactions and their potential applications in therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…